Breakthrough Genomics
PrivateCompany Overview
Breakthrough Genomics operates in Healthcare & Life Sciences and is based in Irvine, California. It was founded in 2017.
Breakthrough Genomics is a healthcare technology company that provides AI-powered genomic data analysis and clinical interpretation software for rare disease diagnosis and cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breakthrough Genomics Comparables
Compare Breakthrough Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomenon Inc. | 84% | |
| Golden Helix | 83% | |
| Gamow Labs, Inc. | 82% |
For institutional investors. Book with your work email.
Breakthrough Genomics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 990% MoM, reaching 1.7K.
- Nov 12, 2024
Monthly visitors grew 1150% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
Breakthrough Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Breakthrough Genomics's valuation, stock price, and market status.
Is Breakthrough Genomics a public or private company?
Breakthrough Genomics is a private company.
What is the current stock price of Breakthrough Genomics?
Breakthrough Genomics is a private company, so its shares have no public market price. Caplight tracks Breakthrough Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Breakthrough Genomics worth (valuation)?
Valuation information for Breakthrough Genomics is not publicly available.
Can I buy Breakthrough Genomics stock?
Breakthrough Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Breakthrough Genomics's last funding round?
Funding round information for Breakthrough Genomics is not publicly available.
Who are the main investors in Breakthrough Genomics?
Investor information for Breakthrough Genomics is not publicly disclosed.
Will Breakthrough Genomics IPO soon?
No public IPO plans have been announced for Breakthrough Genomics.
How can I track Breakthrough Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Breakthrough Genomics's shares on secondary markets.